- Can STOP Trial Velocity Criteria Be Applied to Iranian Children with Sickle Cell Disease?
-
Bavarsad Shahripour R, Mortazavi , Barlinn K, Keikhaei B, Mousakhani H, Azarpazhooh MR, Oghbaee M, Sajedi SA, Kepplinger J, Tubbs RS, Albright K, Alexandrov AV
- KMID: 2223716
- J Stroke.
- 2014 May;16(2):97-101.
BACKGROUND AND PURPOSE: Sickle cell disease (SCD) is strongly linked to stroke across all haplotypes in the pediatric population. Transcranial Doppler (TCD) ultrasound is known to identify the highest risk... -
- CITED
-
- Close
- SHARE
-
- Close
- Timing of Recanalization and Functional Recovery in Acute Ischemic Stroke
-
Tsivgoulis G, Saqqur M, Sharma VK, Brunser A, Eggers J, Mikulik R, Katsanos A, Sergentanis TN, Vadikolias K, Perren F, Rubiera M, Bavarsad Shahripour R, Nguyen HT, Martínez-Sánchez P, Safouris A, Heliopoulos I, Shuaib A, Derksen C, Voumvourakis K, Psaltopoulou T, Alexandrov AW, Alexandrov AV, CLOTBUST-PRO investigators
- KMID: 2500925
- J Stroke.
- 2020 Jan;22(1):130-140.
- doi: 10.5853/jos.2019.01648
Background and Purpose Although onset-to-treatment time is associated with early clinical recovery in acute ischemic stroke (AIS) patients treated with intravenous tissue plasminogen activator (tPA), the effect of the timing... -
- CITED
-
- Close
- SHARE
-
- Close
